Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy

被引:4
|
作者
Yamamoto, Sena [1 ]
Masutani, Eiko [2 ]
Arao, Harue [3 ]
机构
[1] Hakuaikai Sagara Hosp, Dept Nursing, 3-31 Matsubara Cho, Kagoshima, Kagoshima 8920833, Japan
[2] Osaka Univ, Grad Sch Med, Canc Educ & Res Ctr, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Div Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan
关键词
Cognitive dysfunction; Long-term adverse effects; Cancer survivors; Quality of life; Patient-reported outcome measures; ADJUVANT CHEMOTHERAPY; IMPAIRMENT; PERFORMANCE; IMPACT; MANAGEMENT; SYMPTOMS; SEQUELAE; WOMEN;
D O I
10.1007/s12282-020-01062-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Despite contributing to the control of hormone receptor-positive breast cancer, a highly prevalent cancer type, endocrine therapy affects patients' cognitive function. We aimed to identify cognitive decline following the start of endocrine therapy using patient-reported measures and investigate factors associated with cognitive difficulties. Methods This cross-sectional survey used a self-administered, anonymous questionnaire. The participants were 876 patients with breast cancer who experienced subjective cognitive difficulties after starting endocrine therapy. Our sample was recruited from 11 patient advocacy groups, 5 clinics, and 2 hospitals in Japan. The questionnaire assessed subjective cognitive difficulties (30 items), psychological well-being, demographic and clinical information, and other subjective symptoms. Results Of 510 (58.2%) responses, we analyzed 405 (46.2%) questionnaires. Exploratory factor analysis identified three factors of cognitive difficulties: Factor 1, "difficulties in manipulating memory and language;" Factor 2, "difficulties in processing multiple pieces of information;" and Factor 3, "difficulties in maintaining attention and concentration." Factor 1 was the most common type, and it was significantly related to the treatment characteristics of endocrine therapy. Multivariate logistic regression analysis revealed that fewer household members, a history of breast surgery, more severe menopausal symptoms, and greater psychological distress were significantly associated with cognitive difficulties. As cognitive difficulties increased, the proportion of participants suspected to have psychological disorders increased significantly. Conclusions Patients treated with endocrine therapy for breast cancer experience intricately intertwined impairments in several domains of cognitive function. They have an increased risk of psychological disorders corresponding to the degree of subjective cognitive function.
引用
收藏
页码:670 / 682
页数:13
相关论文
共 50 条
  • [21] Self-reported symptoms and interference issues in breast cancer patients
    Alvarez, R. H.
    Hartman, S.
    Bosch, B.
    Kendrick, D.
    Cohen, L.
    Fridman, J.
    Ottersen, D.
    Walcott, K.
    Ware, S.
    Castro, I.
    Thomas, J.
    Niu, J.
    Ahn, E.
    Denny, D.
    Markman, M.
    [J]. CANCER RESEARCH, 2016, 76
  • [23] Risk factors for self-reported anxiety in subjective cognitive decline
    Amador, K.
    Masurkar, A.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 70 : S302 - S302
  • [24] Self-reported cognitive function among testicular cancer survivors treated with chemotherapy
    Skoogh, J.
    Steineck, G.
    Stierner, U.
    Cavallin, Stahl E.
    Olofsson, U.
    Wallin, A.
    Gatz, M.
    Johansson, B.
    [J]. PSYCHO-ONCOLOGY, 2008, 17 (03) : S89 - S90
  • [25] ASSOCIATION OF SELF-REPORTED SLEEP WITH COGNITIVE DECLINE AND INCIDENT MILD COGNITIVE IMPAIRMENT
    Derby, C.
    Buxton, O. M.
    Wang, C.
    Lipton, R.
    Katz, M.
    [J]. GERONTOLOGIST, 2016, 56 : 14 - 15
  • [26] Predictors of self-reported pain medication in women treated for primary breast cancer?
    Johannsen, Maja
    Frederiksen, Yoon
    Maja, O'Connor
    Anders, Bonde
    Inger, Hojris
    Zachariae, Robert
    [J]. PSYCHO-ONCOLOGY, 2016, 25 (SP. S3) : 93 - 93
  • [27] INTERNET-DELIVERED COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA IN BREAST CANCER SURVIVORS: EFFECTS ON SELF-REPORTED COGNITIVE FAILURES
    Stroem, Louise
    Amidi, Ali
    Damholdt, Malene
    Dahlgaard, Jesper
    Thomdike, Frances
    Ritterband, Lee
    Zachariae, Robert
    [J]. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2018, 25 : S153 - S153
  • [28] Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study
    Schilder, C. M. T.
    Seynaeve, C.
    Linn, S. C.
    Boogerd, W.
    Beex, L. V. A. M.
    Gundy, C. M.
    Nortier, J. W. R.
    van de Velde, C. J. H.
    van Dam, F. S. A. M.
    Schagen, S. B.
    [J]. PSYCHO-ONCOLOGY, 2012, 21 (05) : 479 - 487
  • [29] Self-reported stress and risk of breast cancer
    Roberts, FD
    Newcomb, PA
    TrenthamDietz, A
    Storer, BE
    [J]. CANCER, 1996, 77 (06) : 1089 - 1093
  • [30] DIFFERENCES IN SELF-REPORTED ATTENTIONAL FATIGUE PRIOR TO THE INITIATION OF RADIATION THERAPY IN PATIENTS WITH BREAST CANCER AND PROSTATE CANCER
    Merriman, John
    Dodd, Marylin
    Lee, Kathryn
    Paul, Steven
    Cooper, Bruce
    Miaskowski, Christine
    [J]. ONCOLOGY NURSING FORUM, 2010, 37 (03) : E200 - E201